Tag: Coronavirus vaccine

Dr. Anthony Fauci, director of the National Institute for Allergy and Infectious Diseases, arrives to testify before the House Select Subcommittee on the Coronavirus Crisis hearing in Washington, D.C., July 31, 2020. (Image by Kevin Dietsch/Pool/Reuters)

Fauci says a coronavirus vaccine is ‘unlikely’ by U.S. election

Key Points The CDC has asked states to ready facilities to distribute a coronavirus vaccine by Nov. 1. Dr. Anthony Fauci said at a health conference that it’s more likely a vaccine will be ready by “the end of the year.” Drug companies Moderna and Pfizer are racing to complete patient enrollment for their late-stage vaccine trials by the end […]

Read more ›
This photograph depicted an Enteric Diseases Laboratory Branch (EDLB) public health scientist, holding up a glass slide used for a run on a sequencing machine (Image by James Gathany/CDC)

Trump administration tells US states to be ready to distribute coronavirus vaccine by November 1

Letter from CDC head pushes for facilities to be fully operational two days before US election The Trump administration has urged US states to get ready to distribute a potential Covid-19 vaccine by November 1, in the latest sign of the accelerating race to deliver a vaccine by year’s end. “CDC urgently requests your assistance in expediting applications for these […]

Read more ›
A volunteer received a coronavirus vaccine as part of clinical trials at Sechenov First Moscow State Medical University in June. (Image by Sechenov Medical University Press Office, via Getty Images)

Your Monday Briefing

We’re covering Russian plans for a nationwide coronavirus vaccination campaign, Britain’s dilemma if President Trump loses in November and a far-right extremist group in Germany. Russia plans mass vaccination after shortened trials Russia is planning a nationwide vaccination campaign in October with a coronavirus vaccine that has yet to complete clinical trials. The announcement has raised international concerns that the […]

Read more ›
Roberto Speranza, Italian health minister, center facing camera, is taken on a tour of the labs at IRBM in Pomezia, Italy, on June 18, 2020. (Geraldine Hope Ghelli)

Trial vaccine developed by Oxford and made in Italy gains backers

In it, packed with dry ice, were several tiny vials. Each one held a few drops of “seed stock,” a starter kit for the production of a potential vaccine for the novel coronavirus.
The company’s job was to turn a few droplets into an amount large enough for 13,000 people — a sufficient quantity to perform ­large-scale trials unfolding on several continents.
“We could really feel the pressure,” said Francesco Calvaruso, the production manager of Advent, which needed two months to grow, filter and purify a trial vaccine known as AZD1222.

Read more ›